Verastem Inc. announced that as of January 25, 2026, all outstanding cash warrants had been exercised, resulting in net proceeds of $29.4 million. Following the exercise, no cash exercise warrants remain outstanding. The company’s cash, cash equivalents, and investments stood at $205 million as of December 31, 2025, and on a pro forma basis, including the warrant proceeds, totaled $234 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260204097979) on February 04, 2026, and is solely responsible for the information contained therein.